Rianimazione.net

1. Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 2003; 31: 946-9552. Friedman G, Silva E, Vincent JL: Has the mortality of septic shock changed with time? Crit Care Med 1998; 26:2078-20863. Sackett DL: Rules of evidence and clinica! recommendations on the use of antithrom botic agents. Chest 1989; 95:2S-4S4. Sprung CL, Bernard GR, Dellinger RP: In troduction. Intensive Care Med 2001; 27(SuppD:S1-S25. Rivers E, Nguyen B, Havstad S, et a!: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-13776. Weinstein MP, Refler LP, Murphy JR, et al : The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteraemia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5:35-537. Blood F, Schmidt E, Nitenberg G, et a!: Earlier positivity of central venous versus pe ripheral blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998; 36:105-1098. Mermen LA, Maki DG: Detection of bacteremia in adults: Consequences of culturing an inadequate volume of blood. Ann Intern Med 1993; 119:270-2729. McCabe WR, Jackson GG: Gram negative bacteremia. Arch Intern Med 1962; 110: 92-10010. Kreger BE, Craven DE, McCabe WR: Gram negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68:344-35511. Leibovici L, Shraga, Drucker M, et a! The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-38612. Ibrahim EH, Sherman G, Ward S, et a! The influence of inadequate antimicrobial! treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146 -15513. Hatala R, Dinh T, Cook Di: Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis. Ann Intern Med 1996; 124:717-72514. Ali MZ, Goetz MB: A meta-analysis of the relative efficacy and toxicity of singe daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24:796-80915. Amsden GW, Bailow CH, Bertino JS: Pharmacokinetics and Pharmacodynamcis of Anti-infective Agents. In: Principles and Practice of Infectious Diseases. Fifth Edition. Mandeli CL, Bennett JE, Dolin R (Eds). Philadelphia, Churchill Livingstone, 2000, pp 253-26116. Hyatt JM, McKinnon PS, Zimmer CS, et al:The importance of pharmacokineticlphar macodynamic surrogate markers to out comes. Focus on antibacterial agents. Clin Pharmacokinet 1995; 28:143-16017. Jimenez MF, Marshall JC: Source control in the management of sepsis. Intensive Care Med 2001; 27:S49-S6218. Bufalari A, Ciustozzi C, Moggi L: Postoperative intraabdominal abscesses: Percutaneous versus surgical treatment. Acta Chir Belg 1996; 96:197-20019. Moss RL, Musemeche CA, Kosloske AM: Necrotizing fascitis in children: Prompt recognition and aggressive therapy improve survival. JPediatr Surg 1996; 31:1142-1 146 20. Centers for.Disease Control and Prevention:Guidelines for the Prevention of Intravascu lar Catheter-Related Infections. MMWR 2002; 51:1-2921. O'Crady NP, Alexander M, DeHinger EP, et al: Guidelines for the prevention of intra vascular catheter-related infections. Clin Infect Dis 2002; 35:1281-130722. Choi PTL, Yip C, Quinonez LC, et al: Crystalloids vs. colloids in fluid resuscitation: Asystematic review. Crit Care Med 1999; 27: 200-21023. Cook D, Guyatt G: Coiloid use for fluid resuscitation: Evidence and spin. Ann In tern Med 2001; 135:205-20824. Schierhout C, Roberts I: Fluid resuscitation with colloid or crystalloids solutions in critically iii patients: A systematic review of randomized trials. BMJ 19 316:961-964 25. Hollenberg SM, Ahrens TS, Astiz ME, et al:Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 1999; 27:639-66026. LeDoux D, Astiz ME, Carpati CM, et al:Effects of perfusion pressure on tissue per fusion in septic shock. Crjt Care Mec! 2000; 28:2729-273227. Regnier B, Rapin M, Gory G, et al: Haemodynamic effects of dopamine in septic shock. Intensive Care Med 1977; 3:47-5328. Martin C, Papazian L, Perrin C, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-183129. Martin C, Viviand X, Leone M, et al: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28:2758-276530. De Backer D, Creteur J, Silva E, et al: Effects of dopamine, norepinephrine, and epi nephrine on the splanchnic circulation in septic shock: Which is best? Cr11 Care Mec! 2003; 31:1659-166731. Bellomo R, Chapman M, Finfer 5, et al:Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zea land Intensive Care Society (ANZICS) Clin ical Trials Croup. Lancet 2000; 356: 2139-214332. Kellum 1, Decker J: Use of dopaniine in acute renal failure: A meta-analysis. Crit Care Mec! 2001; 29:1526-153133. Sharshar T, Bianchard A, Paillard M, et al : Circulating vasopressin levels in septic shock. Crit Care Med. 2003; 31:1752-175834. Holmes CL, Patel BM, RusseH JA, et al: Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989-100235. Malay MB, Ashton RC, Landry DW, et al: Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47:699-70536. Holmes CL, Walley KR, Chittock DR, et al: The effects of vasopressin on Haemodynamic and renal function in severe septic shock: A case series. Intensive Care Mec! 2001; 27:1416-142137. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Eng J Med. 1995; 333:1025-103238. Hayes MA, Timmins AC, Yau EHS, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N. Eng J Med. 1994; 330:1717-172239. Annane D, Sebille V, Charpentier C, et al :Effect of treatment with low doses of hydro cortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-87140. Briegel J, Forst H, Halier M, et al: Stress doses of hydrocortisone reverse hyperdy namic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Mec! 1999; 2 7:723-73241. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-65042. Annane D, Sebille V, Troche G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-104543. Annane D, Cavaillon JM: Corticosteroids in sepsis: From bench to bedside? Shock 2003; 20:197-20744. Marik PE, Zaioga CP: Adrenal insufficiency during septic shock. Crit Care Med. 2003; 3 1: 141-14545. Cooper MS, Stewart PM: Corticosteroid in sufficiency in acutely ill patients. N Eng J Med 2003; 348:727-73446. Keh D, Boehnke T, Weber-Carstens 5, et al:Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: A double-b randomized, placebo controlled, crossover study. Am J Respir Crit Care Mec! 2003; 167:512-52047. Bone RC, Fisher CI, Clemmer TP: A con trolled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Eng J Med 1987; 3 17:653-65848. Cronin L, Cook DJ, Carlit J, et al: Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995; 23:1430-1439 49. The Veterans Administration Systemic Sep sis Cooperative Study Group: Effect on high-dose glucocorticoid therapy on mor tality in patients with clinical signs of sep sis.NEnglJMed 1987; 317:659-66550. Bernard CR, Vincent IL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. NEngi JMed 2001; 344:699-70951. Hébert PC, WelIs C, Blajchrnan MA, et al: A multicenter, randomized, controlled clinical trial of transfusion in critical care. N EngI J Med 1999; 340:409-41752. Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. fA/VIA 1993; 269:3024-302953. Lorente lA, Landfn L, De Pablo R, et al: Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med 1993; 21:1312-131854. Corwin HL, Cettinger A, Rodriguez RM, et al: Efficacy of recombinant human erythro poietin in the critically iii patient: A randomized double-blind, placebo-controlled trial. Crit Care Med. 1999; 27:2346-235055. Corwin HL, Gettinger A, Peari RC, et al: Efficacy of recombinant human erythropoi etin in critically ill patients. JAMA 2002; 288:2827-283556. Practice parameter for the use of fresh frozen plasma, cryoprecipitate, and plate lets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. JAMA 1994; 271:777-78157. Guidelines for red blood ceil and plasma transfusion for adults and children. Report of the Working Croup. CMAJ 1997; 156(Suppl):S1-S2458. Practice guidelines for blood component therapy. A report by the American Society of Anaesthesiologists Task Force on Blood Component Therapy. Anaesthesiology 1996; 84:732-74759. Warren BL, Eid A, Singer P, et al: High-dose antithrombin III in severe sepsis. A randomized controlled trial. JAMA 2001; 286: 1869-187860. Amato MB, Barbas CS, Medeiros DM, et al: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Eng J Med 1998; 338:347-35461. Stewart TE, Meade MO, Cook DJ, et al: Evaluation of a ventilation strategy to pre vent barotrauma in patients at high risk for acute respiratory distress syndrome. Pres sure- and Volume-Limited Ventilation Strategy Croup. N Eng J Med 1998; 338:355-36162. Brochard L, Roudat-Thoraval F, Roupie E, et al: Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trial Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med. 1998; 158:1831-183863. Brower RG, Shanholtz CB, Fessier HE, et al: Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999; 27:1492-149864. Brower RG, Fessler HE: Mechanical ventilation in acute lung injury and acute respiratory distress syndrome. Curr Chest Med 2000; 21:491-51065. Eichacker PQ, Gerstenberger EP, Banks SM, et al: Meta-analysis of acute lung injury and acute respiratory distress syndrome tn- ala testing low tidal volumes. Am J Respir Crit Care Mec! 2002; 166:1510-151466. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Eng J Med 2000; 342:1301-130867. Hickling KG, Walsh J, Henderson S, et al: Low mortality rate in adult respiratory distress syndrome using low-volume, pres sure-limited ventilation with permissive hypercapnia: A prospective study. Crit Care Med 1994; 22:1568-157868. Bidani A, Tzouanakis AE, Cardenas VJ, et al:Permissive hypercapnia in acute respiratory failure. Fa/l'lA 272:957-96269. Marini JJ, Ravenscraft SA: Mean airway pressure: Physiologic determinants and clinical importance-Part I: Physiologic de terminants and measurements. Crit Care Med 1992; 20:1461-147270. Gattinoni L, Marcolin R, Caspani ML, et al:Constant mean airway pressure with different patterns of positive pressure breathing during the adult respiratory distress syndrome. Bui! Eur Physiopathol Respir 1985; 2 1:275-27971. Pesenti A, Marcolin R, Prato P, et al: Mean airway pressure vs. positive end-expiratory pressure during mechanical ventilation. Crit Care Med 1985; 13:34-3772. Stocker R, Neff T, Stein 5, et al: Prone positioning and low-volume pressure limited ventilation improve survival in patients with severe ARDS. Chest 1997; 111: 1008 -10 1773. Lamm WJ, Graham MM, Albert RE: Mechanism by which prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med.1994; 150:184-19374. Jolliet P, Bulpa P, Chevrolet JC: Effects of the prone position on gas exchange and hemodynamics in severe acute respiratory distress syndrome. Crit Care Mec! 1998; 26: 1977-198575. Gattinoni L, Tognoni G, Pesenti A, et al: Effect of prone positioning on the survival of patients with acute respiratory failure. NEng J Med. 2001; 345:568-57376. Chatte G, Sab JM, Dubois JM, et al: Prone position in mechanically ventilated patients with severe acute respiratory failure. Am Respir Crit Care Med 1997; 155:473-47877. Drakulovic M, Torres A, Bauer T, et al: Su pine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: A randomised trial. Lancet 1999; 354:1851-185878. Esteban A, Alia I, Tobin MJ, et al: Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1999; 159:512-51879. Ely EW, Baker AM, Dunagan DP, et al: Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N. Eng. J. Med 1996; 335:1864-186980. Esteban A, Alia I, Gordo F, et al: Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. The Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1997; 156:459 -46581. KolIef MH, Levy NT, Ahrens TS, et al: The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest 1998; 114:541-54882. Kress JP, Pohlman AS, O'Connor MF, et al:Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Eng J Med. 2000; 342: 1471-147783. BrookAD, Ahrens TS, Schaiff R, et al: Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27:2609-261584. Giostra E, Magistris MR, Pizzolato G, et al: Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination. Chest 1994; 106:210-22085. Rossiter A, Souney PF, McGowan S, et al:Pancuronium-induced prolonged neuromuscular blockade. Crit Care Mec! 1991; 19:1583-158786. Partridge BL, Abrams JH, Bazemore C, et al: Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 1990; 18:1177-117987. Vandenheyden BA, Reynolds HN, Gerold KB, et al: Prolonged paralysis after long term vecuronium infusion. Crit Care Med 1992; 20:304-30788. Meyer KC, Prielipp RC, Grossman JE, et al: Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994; 78:772-77489. Manthous CA, Chatila W: Prolonged weak ness after withdrawal of atracurium. Am Respir Crit Care Mec! 1994; 150:1441-144390. Prielipp RC, Coursin DB, Scuderi PE, et al: Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995; 81:3-1291. Brandom BW, Yellon FF, Lloyd ME, et al: Recovery from doxacurium infusion administered to produce immobility for more than four days in pediatric patients in the intensive care unit. Anesth Analg 1997; 84: 3 07-3 1492. Rudis Ml, Sikora CA, Angus E, et al: A prospective, randomized, controlled evalua tion of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med. 1997; 25:25575-2558393. Frankel H, Jeng J, Tilly E, et al: The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive cane unit. Am Surg 1996; 62: 503-50694. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Eng J Med 2001; 345: 1359 -136795. Finney SJ, Zekveld C, Elia A, et al: Glucose control and mortality in critically ill patients. JAMA 2003; 2041-204796. Van den Berghe G, Wouters PJ, Bouillon R, et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-36697. Klein 5, Kinney J, Jeejeebhoy K, et al: Nutrition support in clinical practice: Review of published data and recommendations for future research directions. A summary of a conference sponsored by the National Institute of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am Cur Nutr 1997; 66:683-70698. Mehta RL, McDonald B, Gabbai FB, et al: A randomized clinical trial of continuous versus intermittent dialysis for acute renal fail one. Kidney Int. 2001; 60:1154-116399. Kellum J, Angus DC, Johnson JP, et al: Continuous versus intermittent renal replacement therapy: A meta-analysis. Inten sive Care Med. 2002; 28:29-37100. Cooper DJ, Walley KR, Wiggs BR, et al: Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: A prospective, controlled clinical study. Ann Intern Med! 1990; 112: 492-498101. Mathieu D, Nervier R, Bill and V, et al: Effects of bicarbonate therapy on hemody namics and tissue oxygenation in patients with lactic acidosis: A prospective, con trolled clinical study. Crit Care Med! 1991; 19: 1352-1356102. Cade JF: High risk of the critically iii for venous thromboembolism. Crit Care Med.
1982; 10:448-450103. Belch JJ, Lowe GD, Ward AG, et al: Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med 1981; 26:115-117104. Samama MM, Cohen AT, Darmon JY, et al: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Eng. J. Med 1999; 341: 793-800105. Borrego E, Bank S, Margolis I, et al : Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in pa tients who are critically ill. Am J Med 1985; 79:62-64106. Bresalier RS, Grende.JH, Cello JP, et al : Sucralfate versus titrated antacid for the prevention of acute stress-related gastrointestinal haemorrhage in critically ill patients. Am JMed 1987; 83:110-116107. Cook D, Guyatt G, Marshall , et al: A comparison of Sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. NEnglJMed 1998; 338:791-797108. Stothert JC, Simonowitz DA, Dellinger EP, et al : Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill Ann Surg 1980; 192: 169-174109. Pollard Ai, Britto J, NadelS, et al Emer gency management of meningococcal disease. .4rch Dis Child 1999; 80:290-296110. Kanter RK, Zimmerman JJ, Strauss RH, et al : Paediatric emergency intravenous access. Evaluation of a protocol Am i Dis Child 1986; 140:132-134111. Ngo NT, Cao XT, Kneen R, et al: Acute management of dengue shock syndrome: A randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001; 32:204-213112. Carcillo JA, Davis AL, Zaritsky A: Role of early fluid resuscitation in pediatric septic shock. JAMA 1991; 266:1242-1245113. Powell KR, Sugarman LI, Eskenazi AE, et al: Normalization of plasma arginine vaso pressin concentrations when children with meningitis are given maintenance plus re placement fluid therapy. J Pediatr 1991; 117: 515-522114. Ceneviva G, Paschail lA, Maffei F, et al: Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998; 102: e19115. Keeley SR, Bohn DI: The use of inotropic and afterload-reducing agents in neonates. Clin Perinatol 1988; 15:467-489116. Roberts JD Jr, Fineman JR, Morin FC III, et al: Inhaled nitric oxide and persistent pulmonary hypertension of the new born. Inhaled Nitric Oxide Study Group. N Eng J Med 1997; 336:605-610117. Barton P, Garcia J, Kouatli A, et al: Hemodynamic effects of i. v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, international study. Chest 1996; 109:1302-1312118. Lindsay CA, Barton P, Lawless S, et al: Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. i Pediatr 1998; 132:329 -334119. Irazuzta lE, Pretzlaff RK, Rowin ME: Amrinone in pediatric refractory septic shock:An open-label pharmacodynamic study. Pediatric Group Care Med 2001; 2:24-28120. Lauterbach R, Pawlick D, Kowalczyk D, et al: Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: A placebo controlled double-blind trial. Crit Care Med 1999; 27:807-814121. Carciilo JA, Fields AI, American College of Critical Care Medicine Task Force Committee Members: Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002; 30:1365-1378122. De Kleijn ED, Joosten KF, Van Rijn B, et al : Low serum cortisol in combination with high adrenocorticotrophic hormone con centrations are associated with poor out come in children with severe meningococcal disease. Pediatr Infect Dis 2002; 21: 330 -336123. Riordan FA, Thomson AP, Ratciiffe JM, et al: Admission cortical and adrenocorticotro phic hormone levels in children with me ningococcal disease: Evidence of adrenalin sufficiency? Crit Care Med 1999; 27: 2257-226 1124. Mio M, U T, Aye M, et a!: Hydrocortisone in the management of dengue shock syndrome. Southeast Asiari Trop Med Public Health 1975; 6:573-579125. Sumarmo, Talogo W, Asrin A, et a!: Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 1982; 69: 45-49126. Hazelzet JA, de Kleijn ED, de Groot R: Endothelial protein C activation in meningo coccal sepsis. N Eng J Med 2001; 345: 1776-1777127. de Kleijn ED, de Groot R, Hack CE, et al:Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purport fulminans: A randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 2003; 31:1839-1847128. Bilgin K, Yaramis A, Haspolat K, et al: A randomized trial of granulocyte-rnacroph age colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics : 2001; 107:36-41129. La Gamma EF, De Castro MH: What is the rationale for the use of granulocyte and granulocyte-macrophage colony stimulating factors in the neonatal intensive care unit? Acta Paediatr SappI 2002; 91: 109 -116130. Chaibou M, Tucci M, Dugas MA, et al: Clinically significant upper gastrointestinal bleeding acquired in a pediatric intensive care unit: A prospective study. Pediatrics :1998; 102:933-938131. Gauvin F, Dugas M, Chaibou M, et a!: The impact of clinically significant upper gastrointestinal bleeding in a pediatric intensive care unit. Pediatr Crit Care Med 2001; 2:294-298132. Alejandria MM, Lansang MA, Dans LF, et al:Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev 2002; (1):CDOO1O9O133. Meyer DM, Jessen ME: Results of extracorporeal membrane oxygenation in children with sepsis. The Extracorporea! LifeSupp6rt Organization. Ann Thorac Surg 1997; 63: 756-761134. Goldman AP, Kerr SI, Butt W, et a!: Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997; 349:466-469135. Brochard L, Rauss A, Benito S, et a!: Com parison of three methods of graduai with drawal from ventilatory support during weaning from mechanical ventilation. Am Respir Crit Care Med

Source: http://rianimazione.net/files/bibliografiasespsi2004.pdf